4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-017663
Options or other derivatives
- CEO and CFO acquired 1,073,731 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Patel Snehal CEO and CFO | 2022-06-22 | Grant or award · Stock Options | +1,048,723 | 1,048,723 | D | ||
| Patel Snehal CEO and CFO | 2022-06-22 | Grant or award · Stock Options | +25,008 | 1,073,731 | I | ||
Loading xslF345X03/ownership.xml…